AG
ORMP icon

Algert Global’s Oramed Pharmaceuticals ORMP Stock Holding History

Algert Global’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$139K Buy
28,958
+9,740
+51% +$38.8K ﹤0.01% 1209
2026
Q1 		$65.3K Buy
19,218
+7,150
+59% +$24.3K ﹤0.01% 1124
2025
Q4 		$34.4K Buy
+12,068
New +$31.1K ﹤0.01% 1120
2024
Q1 		– Sell
-14,680
Closed -$33.9K – 1213
2023
Q4 		$33.9K Hold
14,680
– – ﹤0.01% 1108
2023
Q3 		$38.3K Buy
+14,680
New +$46.2K ﹤0.01% 1076

Other funds holding ORMP

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Algert Global's ORMP Position: Q2 2026 in Review

Algert Global increased its Oramed Pharmaceuticals (ORMP) stake by 51% in Q2 2026, buying an estimated $38.8K and bringing the position to 28,958 shares worth $139K. The position accounts for ﹤0.01% of the portfolio, ranked #1209.

Algert Global first reported a position in ORMP in Q3 2023 and has held it in 5 quarters since. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • Algert Global held 28,958 shares of Oramed Pharmaceuticals worth $139K as of Q2 2026.
  • Algert Global bought 9,740 Oramed Pharmaceuticals shares in Q2 2026, an estimated $38.8K.
  • Oramed Pharmaceuticals made up ﹤0.01% of Algert Global's portfolio in Q2 2026, its #1209 holding.
  • Algert Global first reported a position in Oramed Pharmaceuticals in Q3 2023 and has held it in 5 quarters since.
  • 84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.